SCHEMBL14212864

SCHEMBL14212864

CC1C[C@H]2CC2/C=C\C=C\C(=N/O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 4/20 0.80
MAPT P10636 3/20 0.59
HSP90AA1 P07900 2/20 0.59
GAA P10253 1/20 0.59
RAB9A P51151 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
NLRP3 Q96P20 1/20 0.59
CBR1 P16152 1/20 0.59
PTGS2 P35354 1/20 0.59
ACLY P53396 1/20 0.59
FTO Q9C0B1 1/20 0.59
MEN1 O00255 1/20 0.59
ALDH1A1 P00352 1/20 0.59
HPGD P15428 1/20 0.59
KMT2A Q03164 1/20 0.59
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
STAT6 P42226 1/20 0.37
SMAD3 P84022 1/20 0.37
SMAD2 Q15796 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14182165 1.00 HSP90AB1 (0.80) HSP90AB1MAPTHSP90AA1GAARAB9A
SCHEMBL14182170 1.00 HSP90AB1 (0.80) HSP90AB1MAPTHSP90AA1GAARAB9A
SCHEMBL14212857 1.00 HSP90AB1 (0.80) HSP90AB1MAPTHSP90AA1GAARAB9A
SCHEMBL10149964 1.00 HSP90AB1 (0.80) HSP90AB1MAPTHSP90AA1GAARAB9A
SCHEMBL19418325 0.92 HSP90AB1 (0.68) HSP90AB1MAPTHSP90AA1GAARAB9A
Cycloproparadicicol SCHEMBL10150412 0.89 HSP90AB1 (1.00) HSP90AB1MAPTHSP90AA1GAARAB9A
Cycloproparadicicol SCHEMBL10149963 0.89 HSP90AB1 (1.00) HSP90AB1MAPTHSP90AA1GAARAB9A
Cycloproparadicicol SCHEMBL14212855 0.89 HSP90AB1 (1.00) HSP90AB1MAPTHSP90AA1GAARAB9A
Cycloproparadicicol SCHEMBL20840799 0.89 HSP90AB1 (1.00) HSP90AB1MAPTHSP90AA1GAARAB9A
Cycloproparadicicol SCHEMBL2622302 0.89 HSP90AB1 (1.00) HSP90AB1MAPTHSP90AA1GAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108694-A1 Novel Macrocycles and Uses Thereof NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2008-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108694-A1 Novel Macrocycles and Uses Thereof BDKRB1, RPS4Y1, GRK4 HSP90AB1 3784/4885MAPT 4737/4885HSP90AA1 4330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.